Concepedia

Publication | Open Access

Benfotiamine and Cognitive Decline in Alzheimer’s Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial

DOIFull Paper Access

100

Citations

64

References

2020

Year

Gary E. Gibson, José A. Luchsinger, Rosanna Cirio, Huan‐Lian Chen, Jessica Franchino‐Elder, Joseph A. Hirsch, Lucien Bettendorff, Zhengming Chen, Sarah A. Flowers, Linda M. Gerber,
Journal of Alzheimer s Disease

Abstract

Oral benfotiamine is safe and potentially efficacious in improving cognitive outcomes among persons with MCI and mild AD.

References

YearCitations

Page 1